نتایج جستجو برای: cyp1b1

تعداد نتایج: 990  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Grace S Leung Masahiko Kawai Jenny K Tai Jie Chen Stelvio M Bandiera Thomas K H Chang

Mammalian testis expresses xenobiotic-metabolizing enzymes, including cytochrome P450 1B1 (CYP1B1), which catalyzes the bioactivation of procarcinogens and other chemicals. The factors that control testicular expression of CYP1B1 are largely not known. In the present study, we investigated the influence of age and pituitary, gonadal, and thyroid hormones on CYP1B1 expression in rat testis. Immu...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2004
Dharamainder Choudhary Ingela Jansson Ivaylo Stoilov Mansoor Sarfarazi John B Schenkman

The cytochrome P450 family 1 (CYP1) is considered to be one of the xenobiotic-metabolizing enzyme families and is responsible for oxidative metabolism of polycyclic aromatic hydrocarbons. For example, mouse Cyp1b1 was originally identified as the enzyme responsible for oxidative metabolism of 7,12-dimethylbenz(alpha)anthracene (DMBA). A comparison of the kinetics of this metabolism by mouse and...

Journal: :Hypertension 2012
Brett L Jennings Larry J Anderson Anne M Estes Fariborz A Yaghini Xiao R Fang Jason Porter Frank J Gonzalez William B Campbell Kafait U Malik

Cytochrome P450 1B1 contributes to the development of angiotensin II-induced hypertension and associated cardiovascular pathophysiology. In view of the critical role of angiotensin II in the kidney, as well as in salt and water homeostasis, and blood pressure regulation, we determined the contribution of cytochrome P450 1B1 to renal dysfunction and injury associated with angiotensin II-induced ...

Journal: :Cancer research 1997
G I Murray M C Taylor M C McFadyen J A McKay W F Greenlee M D Burke W T Melvin

Cytochrome P450 CYP1B1 is a recently cloned dioxin-inducible form of the cytochrome P450 family of xenobiotic metabolizing enzymes. An antibody raised against a peptide specific for CYP1B1 was found to recognize CYP1B1 expressed in human lymphoblastoid cells but not to recognize other forms of cytochrome P450, particularly CYP1A1 and CYP1A2. Using this antibody, the cellular distribution and lo...

2009
Simone Helmig

PCB Polychlorinated biphenyls PAH Polycyclic aromatic hydrocarbons TCDD Tetrachlorodibenzo-p-dioxin DMOS Dimethyl sulfoxide [Tm; dF; dT; T] Fluorescence data were converted to derivative melting curves by plotting the negative derivative of the fluorescence with respect to temperature vs. temperature [-(dF/dT) vs. T] and show two different melting maxima (Tm), one for each allele. PCR Polymeras...

Journal: :Cancer research 2001
Y Ko J Abel V Harth P Bröde C Antony S Donat H P Fischer M E Ortiz-Pallardo R Thier A Sachinidis H Vetter H M Bolt C Herberhold T Brüning

Tobacco use is causally associated with head and neck squamous cell cancer (HNSCC). Here, we present the results of a case-control study that investigated the effects that the genetic variants of the cytochrome (CYP)1A1, CYP1B1, glutathione-S-transferase (GST)M1, GSTT1, and GSTP1 genes have on modifying the risk of smoking-related HNSCC. Allelisms of the CYP1A1, GSTT1, GSTM1, and GSTT1 genes al...

Journal: :Mutagenesis 2014
Simone Helmig Sibylle Wenzel Hagen Maxeiner Joachim Schneider

Benzo(a)pyrene (BaP), a primary component of tobacco smoke, is activated by cytochrome P450 1B1 (CYP1B1). Smokers homozygous for the C-allele (*1/*1) at the CYP1B1 Leu432Val polymorphism have shown increased CYP1B1 expression, compared to smokers homozygous for the G-allele *3/*3. Since no difference has been shown in CYP1B1 expression between both genotypes in non-smokers, we assumed that the ...

Journal: :Molecular cancer therapeutics 2008
Tristan M Sissung Romano Danesi Douglas K Price Seth M Steinberg Ronald de Wit Muhammad Zahid Nilesh Gaikwad Ercole Cavalieri William L Dahut Dan L Sackett William D Figg Alex Sparreboom

Using a single nucleotide polymorphism association study in 52 men with prostate cancer receiving docetaxel, we found that individuals carrying two copies of the CYP1B1*3 polymorphic variant had a poor prognosis after docetaxel-based therapies compared with individuals carrying at least one copy of the CYP1B1*1 allele (30.6 versus 12.8 months; P=0.0004). The association between CYP1B1*3 and res...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
John G Gribben David P Ryan Richard Boyajian Robert G Urban Mary L Hedley Kathleen Beach Patrick Nealon Ursula Matulonis Susana Campos Timothy D Gilligan Paul G Richardson Blossom Marshall Donna Neuberg Lee M Nadler

PURPOSE The carcinogen activator cytochrome P450 1B1 (CYP1B1) is expressed on almost all human tumors with rare expression on normal tissues. Anti-CYP1B1-specific T cells kill CYP1B1-expressing tumors, providing the rationale to examine CYP1B1 as a target for immunotherapy. EXPERIMENTAL DESIGN ZYC300, a plasmid DNA of CYP1B1 encapsulated in biodegradable poly-DL-lactide-coglycolide microparti...

2015
Inik Chang Yozo Mitsui Shinichiro Fukuhara Ankurpreet Gill Darryn K. Wong Soichiro Yamamura Varahram Shahryari Z. Laura Tabatabai Rajvir Dahiya Dong Min Shin Yuichiro Tanaka

Despite high protein expression and enzymatic activity of cytochrome P450 1B1 (CYP1B1) in renal cell cancer (RCC), its functional significance has not been elucidated. Here we explored the functional role and regulatory mechanism of CYP1B1 in RCC. Reduction of CYP1B1 levels fail to prevent in vitro tumorigenicity such as proliferation, apoptosis, and cell cycle progression of RCC cells. Moreove...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید